Skip to main content

Boostrix (Tdap) News

US FDA Approves Boostrix for Immunization During Pregnancy for the Prevention of Whooping Cough in Newborn Infants

Boostrix is the first vaccine in the US indicated to help protect infants younger than two months from pertussis (whooping cough) 10 October 2022 – GSK plc (LSE/NYSE: GSK) today announced that the...

FDA approves Boostrix to prevent tetanus, diphtheria, and pertussis in older people

July 8, 2011 - The U.S. Food and Drug Administration today approved Boostrix vaccine to prevent tetanus, diphtheria, and pertussis (whooping cough) in people ages 65 and older. Currently, there are...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Boostrix (Tdap) patient information at Drugs.com